Lyell Immunopharma, Inc. ($LYEL)
ARCH Venture Partners IX, LLC โ 10% Owner
Shares
488,090
Price
$25.61
Total Value
$12,499,984.90
P&L
-25.3% ($3,167,704.10)
Nearby Earnings
Mar 10, 2026
EPS:Est: -2.15
Mar 12, 2026
EPS:-8.23 (est: -2.23)+268.9%
Revenue:$6.00K (est: $20.33K)-70.5%
Transaction Details
| Insider | ARCH Venture Partners IX, LLC |
|---|---|
| Title | 10% Owner |
| Transaction Date | Mar 6, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | See footnote |
| Filing Date | Mar 9, 2026 |
| Shares Purchased | 488,090 |
| Price per Share | $25.61 |
| Total Value | $12,499,984.90 |
| Shares Owned After | 1,426,528 |
| Derivative | No |
| Accession Number | 0001012975-26-000235 |
| Document | View SEC Filing |